These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2324687)

  • 1. Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.
    Perdrizet GA; Ross SR; Stauss HJ; Singh S; Koeppen H; Schreiber H
    J Exp Med; 1990 Apr; 171(4):1205-20. PubMed ID: 2324687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes.
    Koeppen H; Acena M; Drolet A; Rowley DA; Schreiber H
    Eur J Immunol; 1993 Nov; 23(11):2770-6. PubMed ID: 8223853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy.
    Wick M; Dubey P; Koeppen H; Siegel CT; Fields PE; Chen L; Bluestone JA; Schreiber H
    J Exp Med; 1997 Jul; 186(2):229-38. PubMed ID: 9221752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice.
    Freland S; Chambers BJ; Andersson M; Van Kaer L; Ljunggren HG
    J Immunol; 1998 Jan; 160(2):572-9. PubMed ID: 9551890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
    Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H
    Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors.
    Matsumoto K; Leggatt GR; Zhong J; Liu X; de Kluyver RL; Peters T; Fernando GJ; Liem A; Lambert PF; Frazer IH
    J Natl Cancer Inst; 2004 Nov; 96(21):1611-9. PubMed ID: 15523090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgene number-dependent, gene expression rate-independent rejection of Dd -, Kd-, or Dd Kd -transgened mouse skin or tumor cells from C57BL/6 Db Kb mice.
    Inoue Y; Tashiro-Yamaji J; Hayashi M; Kiyonari H; Shimizu T; Ibata M; Yamana H; Kubota T; Tanigawa N; Yoshida R
    Microbiol Immunol; 2011 Jun; 55(6):446-53. PubMed ID: 21434990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4-positive and B lymphocytes in transplantation immunity. I. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes.
    Koeppen HK; Singh S; Stauss HJ; Park BH; Rowley DA; Schreiber H
    Transplantation; 1993 Jun; 55(6):1349-55. PubMed ID: 8100089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.
    Chen Z; Rosten SI; Lord EM; Gaspari AA
    Reg Immunol; 1993; 5(5):285-92. PubMed ID: 8148238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
    Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
    Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal.
    Dunn LA; Evander M; Tindle RW; Bulloch AL; de Kluyver RL; Fernando GJ; Lambert PF; Frazer IH
    Virology; 1997 Aug; 235(1):94-103. PubMed ID: 9300040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help.
    Rees MA; Rosenberg AS; Munitz TI; Singer A
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2765-9. PubMed ID: 2138785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure.
    Frazer IH; De Kluyver R; Leggatt GR; Guo HY; Dunn L; White O; Harris C; Liem A; Lambert P
    J Immunol; 2001 Dec; 167(11):6180-7. PubMed ID: 11714778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL.
    Johnson LL; Hines DL
    Immunology; 1990 Jan; 69(1):85-90. PubMed ID: 2312158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice.
    Ando Y; Beck Y; Tomikawa S; Eriguchi M; Muto T; Takiguchi M
    Transplantation; 1999 Sep; 68(6):904-8. PubMed ID: 10515394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
    Elliott BE; Carlow DA; Ivimey L; Arnold M; Hampton N; Bosman P
    Cancer Res; 1987 Sep; 47(18):4915-23. PubMed ID: 2441856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
    Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
    Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.